Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Based on these metrics and many more, HRMY holds a Value grade of A, while RGEN has a Value grade of D. HRMY sticks out from RGEN in both our Zacks Rank and Style Scores models, so value investors ...

Stocks: Real-time U.S. stock quotes reflect trades reported through ... Sources: FactSet, Tullett Prebon Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange ...

Repligen (RGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

Repligen Corporation (NASDAQ:RGEN), a $9.36 billion market cap leader in bioprocessing technology, has been navigating a ...

H.C. Wainwright lowered the firm’s price target on Repligen (RGEN) to $180 from $240 and keeps a Buy rating on the shares. The firm says the ...

while trimming our Sep-25E target price by 6 per cent to Rs 1,570 due to 10% cut in Retail multiple. New energy development and vertical monetization are key triggers for the stock," it said.

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Details The technical summary data is suggesting a short of RGEN if it tests 164.3 with a downside target of 156.26. We should have a stop loss in place at 164.77 though in case the stock begins to ...

Stock market today: The BSE benchmark surged 318.74 points or 0.42 per cent to reach 77,042.82, after touching an intraday peak of 77,319.50, marking a rise of 595.42 points or 0.77 per cent ...